HPVflash is an email news bulletin that disseminates useful cervical cancer prevention information, including updates on vaccines against the human papillomavirus, to interested persons worldwide. HPVflash emails are emailed only a few times a year.

Publication date: 2015

Region: Global

Part of series: E-newsletters

RHO Cervical Cancer is an online resource for health program managers and decision-makers seeking to prevent cervical cancer in low-resource settings. The site contains information about human papillomavirus and cervical cancer, cervical cancer screening and treatment, and the role of vaccination in cervical cancer prevention.

Publication date: 2015

Region: Global

Part of series: Websites

PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers a wide variety of high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. It is geared for health professionals in the developing and industrialized worlds, as well as for journalists, policymakers, community leaders, parents, and others interested in vaccine-related resources. The resources found on the VRL are collected from a variety of sources, including news media, scientific journals, and leaders in public health.

Publication date: 2015

Region: Global

Part of series: Websites

This fact sheet outlines PATH's role in providing technical assistance to countries for the planning, implementation, and evaluation of human papillomavirus (HPV) vaccination programs. The PATH HPV vaccine team’s activities are channeled through four primary work streams: Gavi, the Vaccine Alliance application support; program planning and implementation; evaluation; and cervical cancer prevention and control strategies.

Publication date: December 2014

Region: Global

Cervical Cancer Action is a global partnership chaired by PATH and aimed at reducing cervical cancer in high-burden, low-income countries. Seven years after its founding and eight years after human papillomavirus vaccines first became available, Cervical Cancer Action offers this snapshot of its accomplishments to date and its vision of the work ahead.

Publication date: April 2014

Region: Global

This fact sheet outlines PATH's work on vaccines and immunization. Topic areas include developing affordable vaccines, designing innovative vaccine technologies, and expanding uptake of existing vaccines. These efforts reduce the burden of malaria, meningitis, diarrheal disease, Japanese encephalitis, pneumococcal disease, influenza, rotavirus, polio, respiratory syncytial virus (RSV), and other infectious diseases in developing countries.

Publication date: December 2013

Region: Global

Part of series: Areas of focus fact sheets

This paper documents the accomplishments of the PATH-led Alliance for Cervical Cancer Prevention (ACCP). The report also presents the state of knowledge about alternative screening strategies prior to the establishment of the partnership, as well as contributions of researchers not affiliated with ACCP.

Author: Gaffikin L, Wittet S, and Sherris J

Publication date: August 2013

Region: Global

Supported by a seed grant from the World Bank, PATH began to focus on cervical cancer in 1991. Since then, our portfolio has expanded tremendously, thanks in large part to grants from the Bill & Melinda Gates Foundation. In this report, we describe our key cervical cancer prevention initiatives.

Publication date: April 2013

Region: Global

The journal Vaccine published a special supplement on the Decade of Vaccines Global Vaccine Action Plan (GVAP) that features articles by PATH contributors and others on the GVAP strategic objectives and the opportunities and challenges associated with its implementation. The 27 articles cover a range of related topics, including vaccine development, financing, access, delivery, and health impact. More than 100 authors contributed to the supplement representing a variety of international and developing-country stakeholders, from civil society and academia to vaccine manufacturers and policymakers.

Author: Glassman A, Zoloa JI, Duran D, et al

Publication date: April 2013

Region: Global

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Vietnam by PATH, the Vietnam National Institute of Hygiene and Epidemiology, and the Vietnam National Center for Health Education and Communication through the HPV Vaccines: Evidence for Impact project. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in Southeast Asia, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: November 2012

Region: Asia

Part of series: HPV vaccination project lessons learned reports

These documents provide stability data as of November 2012 on commonly used, licensed vaccines and stability data as of May 2012 from available data on novel, investigational vaccine formulations. Data are sorted by vaccine in a table format.

Publication date: November 2012

Region: Global

The Global Vaccine Action Plan (GVAP)—endorsed by the 194 Member States of the World Health Assembly in May 2012—is a roadmap to prevent millions of deaths by 2020 through more equitable access to vaccines for people in all communities. The GVAP aims to strengthen routine immunization, introduce new and improved vaccines, and advance research and development for the next generation of vaccines and technologies.

Author: Decade of Vaccines Collaboration

Publication date: May 2012

Region: Global

The Cold Chain Equipment Manager (CCEM) is a Microsoft Access–based software tool. It is accompanied by a user manual, data collection questionnaires, a surveyor’s guide to these questionnaires, and an equipment identification guide. CCEM also comes with practice files, providing new users with practice data to demonstrate how CCEM will analyze cold chain equipment data and facilitate multiyear equipment planning. CCEM version 2.1 is available for download (see below) or, to request a copy on CD, email CCEMinfo@path.org.

Publication date: January 2012

Region: Global

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website summarizing lessons learned to guide cervical cancer prevention program planning in low-resource settings. It demonstrates that formative research is a necessary component of overall planning, discusses formative research issues specific to cervical cancer, and explains how research results may be used for strategic planning within the cervical cancer context.

Publication date: 2012

Region: Global

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It provides methods and tools for designing and conducting an evaluation of a human papillomavirus (HPV) vaccination pilot or demonstration project. It also gives practical examples of using the results to refine an HPV vaccine delivery strategy for national scale-up.

Publication date: 2012

Region: Global

This issue of Directions in Global Health features PATH’s work related to vaccines and immunization. Articles cover the development and introduction of a vaccine to eliminate epidemic meningitis in Africa, use of vaccines and other interventions to prevent cervical cancer, transformation of vaccine distribution systems, expansion of access to rotavirus vaccines, and advancements in vaccine technologies.

Publication date: May 2011

Region: Global

Part of series: Directions in Global Health

This Alliance for Cervical Cancer Prevention fact sheet summarizes evidence published since 2009 on cervical cancer screening approaches for low-resource settings.

Publication date: May 2011

Region: Global

This report assesses global readiness to fight cervical cancer using new approaches and new technologies, especially in regions where the disease is a common killer. It underscores the urgent need for the global community to prioritize cervical cancer prevention and control on global health and development agendas.

Publication date: April 2011

Region: Global

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Uganda by PATH, the Uganda National Expanded Program on Immunization of the Ministry of Health, and the Child Health and Development Centre, through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to almost 10,000 girls in select parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in sub-Saharan Africa, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: January 2011

Region: Global

Part of series: HPV vaccination project lessons learned reports

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It offers practical information to countries that plan to pilot, expand, or scale up human papillomavirus (HPV) vaccination programs. The main focus is on issues specific to HPV vaccination, such as working with a young adolescent target population in school settings and developing community support for HPV vaccination programs.

Publication date: 2011

Region: Global